2018 annual financial data

Redhill Biopharma 2018 Financial results

Direct answer

Revenue was 8,360,000 USD.

Operating income was -39,331,000 USD and net income was -38,820,000 USD.
Operating cash flow was -34,462,000 USD.

Get free Redhill Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
8,360,000 USD
Operating income
-39,331,000 USD
Net income
-38,820,000 USD
Operating cash flow
-34,462,000 USD